The American Gastroenterological Association has released new guidelines for inducing and maintaining remission in Crohn's disease.
GI & Endoscopy
Takeda Pharmaceuticals has announced that the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the FDA have recommended approval for the company's biologic vedolizumab as a treatment for Crohn's disease and ulcerative colitis.
John Vargo, MD, MPH, chairman of gastroenterology and hepatology at the Cleveland Clinic, will serve as the principal investigator of a Cook Medical clinical study of the removability of the new Evolution Esophageal Fully Covered Stent.
The majority of gastroenterologists, 71 percent, see between 25 and 99 patients per week, according to Medscape's Gastroenterologist Compensation Report: 2013.
The American Society for Gastrointestinal Endoscopy has recognized six Texas endoscopy centers through its ASGE Endoscopy Unit Recognition Program.
Advertisement
Researchers from the Royal College of Surgeons in Ireland, Johns Hopkins University in Baltimore and Trinity College Dublin have discovered a new method for the development of anti-diarrheal drugs, according to a MedicalXpress report.
Long Island Digestive Disease Consultants has chosen PriorityOne Group for its IT implementation and management.
Gastroenterologist Dr. Edwin Levine answers questions about healthcare consolidation, the keys to success and his work outside of day-to-day practice.
Norwalk (Conn.) Hospital Physicians and Surgeons has recently added gastroenterologist Suma S. Magge, MD, according to a Stamfordplus report.
A joint Food and Drug Administration advisory committee meeting has been held to review the safety concerns related to vedolizumab, an investigational biologic designed to treat Crohn's disease and ulcerative colitis, according to a medpage today report.